Generating health technology assessment evidence for rare diseases [PDF]
Objectives: Rare diseases are often heterogeneous in their progression and response to treatment, with only a small population for study. This provides challenges for evidence generation to support HTA, so novel research methods are required.
Facey, Karen +6 more
core +1 more source
Self-monitoring of blood glucose in type 2 diabetes: systematic review
Objectives: To examine whether or not self-monitoring of blood glucose (SMBG) is worthwhile, in terms of glycaemic control, hypoglycaemia, quality of life (QoL) and cost per quality-adjusted life-year (QALY), in people with type 2 diabetes (T2DM) who ...
C Clar +5 more
doaj +1 more source
Core Outcome Sets (COS) related to pregnancy and childbirth: a systematic review
Background Systematic reviews often conclude low confidence in the results due to heterogeneity in the reported outcomes. A Core Outcome Set (COS) is an agreed standardised collection of outcomes for a specific area of health.
Marie Österberg +6 more
doaj +1 more source
Health technology assessment in Canada [PDF]
Canada's health system is a unique combination of public financing and private provision. With the significant government role in financing health services, health technology assessment (HTA) has found a ready audience as a form of policy research. In addition, Canada has been a leader in HTA and is entering a phase of deepening and maturation of HTA ...
Renaldo N, Battista +3 more
openaire +2 more sources
Systematic review of economic evaluations of laparoscopic surgery for colorectal cancer [PDF]
Objective Colorectal cancer is one of the most common cancers and the standard surgical treatment for this cancer is open resection (OS), but laparoscopic surgery (LS) may be an alternative treatment.
Aberdeen Health Technology Assessment Group +4 more
core +1 more source
Selecting topic areas for developing quality standards in a resource-limited setting
Variation in practices of and access to health promotion and disease prevention (P&P) across geographical areas have been studied in Thailand as well as other healthcare settings. The implementation of quality standards (QS)—a concise set of evidence-
Roongnapa Khampang +6 more
doaj +1 more source
Counting the cost of public and philanthropic R&D funding: the case of olaparib
Background Lack of transparency around manufacturing costs, who bears the bulk of research and development costs and how total costs relate to the pricing of products, continue to fuel debates.
L. Schmidt, O. Sehic, C. Wild
doaj +1 more source
Bayesian clinical trial designs : Another option for trauma trials? [PDF]
The UK-REBOA Trial is funded by the National Institute for Health Research (NIHR) Health Technology Assessment (HTA) programme (project number 14/199/09). PP was supported by the MRC Network of Hubs for Trials Methodology Research (MR/L004933/1-R/N/P/B1).
Campbell, Marion K. +4 more
core +2 more sources
Strengthening and stretching for rheumatoid arthritis of the hand (SARAH). A randomised controlled trial and economic evaluation [PDF]
Study registration: Current Controlled Trials ISRCTN 89936343.Background - The effectiveness of exercise for improving hand and wrist function in people with rheumatoid arthritis (RA) is uncertain.
+128 more
core +2 more sources
Assessing the impact of England's National Health Service R&D Health Technology Assessment program using the "payback" approach [PDF]
Copyright © Cambridge University Press 2009Objectives: This study assesses the impact of the English National Health Service (NHS) Health Technology Assessment (HTA) program using the "payback" framework.Methods: A survey of lead investigators of all ...
Buxton +10 more
core +1 more source

